Testicular Germ Cell CancerSeminomaNon-Seminoma Testicular CancerStage I Testicular CancerStage II Testicular CancerStage III Testicular CancerStage IV Testicular CancerRelapse Testicular Cancer
Investigational drug(s) / intervention(s)
Biomarker analysis
Biomarker analysis: Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months
Study summary
The main objective of this study is establish the performance of miR371 in management of testicular cancer
Eligibility
Sex
MALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients with suspected testicular cancer, referred to orchiectomy.
* Patients diagnosed with testicular germ cell cancer.
* Age 18-70 years of age.
* Must be able receive information and to consent.
Exclusion Criteria:
* Other prior or concomitant malignancy (other than testicular cancer).
* Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.
Primary outcome measure(s)
miR371 as a biomarker in testicular germ cell cancer at orchiectomy — 5 years To estimate the sensitivity and specificity of miR371 in identifying viable tumour cells at diagnosis
miR371 as a biomarker in testicular germ cell cancer at RPLND — 5 years To estimate the sensitivity and specificity of miR371 in identifying viable tumour cells at RPLND
miR371 as a biomarker in testicular germ cell cancer during chemotherapy treatment — 5 years To estimate the performance of miR371 in monitoring of treatment efficiency (chemotherapy)
miR371 as a biomarker in testicular germ cell cancer and detection of recurrence — 5 years To estimate the performance of miR371 in (early) detection of recurrence
Trial sites (6)
Facility
City
Region
Status
Haukeland University Hospital
Bergen
Norway
Recruiting
Haugesund Hospital
Haugesund
Norway
Recruiting
Oslo University Hospital
Oslo
Norway
Not Yet Recruiting
University Hospital of North Norway
Tromsø
Norway
Recruiting
Sahlgrenska University Hospital
Gothenburg
Sweden
Not Yet Recruiting
Karolinska University Hospital
Stockholm
Sweden
Recruiting
More Haukeland University Hospital trials in Sweden
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
